{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:25:13Z","timestamp":1789770313105,"version":"4.0.1"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/nrl.0b013e31823d7acd","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T19:43:48Z","timestamp":1325792628000},"page":"23-31","source":"Crossref","is-referenced-by-count":9,"title":["Early Diagnosis, Monitoring, and Treatment of Optic Neuritis"],"prefix":"10.1097","volume":"18","author":[{"given":"Jane W.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-3-20210211","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction inpatients with multiple sclerosis. Neurology.","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"R4-3-20210211","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/01.WNL.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology"},{"key":"R5-3-20210211","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/135245850000600305","article-title":"New low-contrast vision charts: reliability and test characteritistics in patients with multiple sclerosis.","volume":"6","author":"Balcer","year":"2000","journal-title":"Mult Scler"},{"key":"R6-3-20210211","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S031716710000915X","article-title":"Retinal nerve fiber layer and future risk of multiple sclerosis.","volume":"35","author":"Costello","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"R7-3-20210211","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1055\/s-2008-1027253","article-title":"Pattern of macular thickness changes measured by ocular coherence tomography in patients with multiple sclerosis.","volume":"225","author":"Gugleta","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"R8-3-20210211","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00415-007-0538-3","article-title":"Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis.","volume":"254","author":"Albrecht","year":"2008","journal-title":"J Neurol"},{"key":"R9-3-20210211","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00415-008-0985-5","article-title":"Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.","volume":"255","author":"Siger","year":"2008","journal-title":"J Neurol"},{"key":"R10-3-20210211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2007.10.020","article-title":"Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis.","volume":"268","author":"Grazioli","year":"2008","journal-title":"J Neurol Sci"},{"issue":"Pt1","key":"R11-3-20210211","first-page":"277","article-title":"An investigation of the retinal nerve fiber layer in progressive multiple sclerosis using optical coherence tomography.","volume":"131","author":"Henderson","year":"2008","journal-title":"Brain"},{"key":"R12-3-20210211","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00415-010-5467-x","article-title":"A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis.","volume":"257","author":"Henderson","year":"2010","journal-title":"J Neurol"},{"key":"R13-3-20210211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10633-007-9112-7","article-title":"A comparison of multifocal and conventional visual evoked potential techniques in patients with optic neuritismultiple sclerosis.","volume":"117","author":"Grover","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"R14-3-20210211","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/1352458509350470","article-title":"Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.","volume":"15","author":"Laron","year":"2009","journal-title":"Mult Scler"},{"key":"R15-3-20210211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ana.21823","article-title":"Neuroplasticity predicts outcome of optic neuritis independent of tissue damage.","volume":"67","author":"Jenkins","year":"2010","journal-title":"Ann Neurol"},{"key":"R16-3-20210211","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"R17-3-20210211","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"R18-3-20210211","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"R19-3-20210211","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","article-title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.","volume":"8","author":"Kappos","year":"2009","journal-title":"Lancet Neurol"},{"key":"R20-3-20210211","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","article-title":"IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.","volume":"66","author":"Kinkel","year":"2006","journal-title":"Neurology"},{"key":"R22-3-20210211","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"R23-3-20210211","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1167\/iovs.08-2970","article-title":"Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.","volume":"50","author":"Wolf-Schnurrbusche","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-3-20210211","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"R25-3-20210211","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/01.wnl.0000294876.49861.dc","article-title":"Optical coherence tomography and disease subtype in multiple sclerosis.","volume":"69","author":"Pulicken","year":"2007","journal-title":"Neurology"},{"key":"R26-3-20210211","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"R27-3-20210211","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/1352458508091367","article-title":"Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.","volume":"14","author":"Costello","year":"2008","journal-title":"Mult Scler"},{"key":"R28-3-20210211","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archneurol.2009.265","article-title":"Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss.","volume":"66","author":"Outteryck","year":"2009","journal-title":"Arch Neurol"},{"key":"R29-3-20210211","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/jnnp.2004.036590","article-title":"Is inflammation important in early PPMS A longitudinal MRI study.","volume":"76","author":"Ingle","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R30-3-20210211","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","article-title":"A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.","volume":"33","author":"Henderson","year":"2010","journal-title":"Brain"},{"key":"R31-3-20210211","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"key":"R32-3-20210211","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/01.wnl.0000319142.37557.a9","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.","volume":"1","author":"Gout","year":"2008","journal-title":"Neurology"},{"key":"R33-3-20210211","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"R34-3-20210211","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1352458507087326","article-title":"Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.","volume":"14","author":"Pueyo","year":"2008","journal-title":"Mult Scler"},{"key":"R35-3-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1352458506071196","article-title":"Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis.","volume":"13","author":"Feuillet","year":"2007","journal-title":"Mult Scler"},{"key":"R36-3-20210211","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","article-title":"Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.","volume":"66","author":"Burkholder","year":"2009","journal-title":"Arch Neurol"},{"key":"R37-3-20210211","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"R38-3-20210211","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuroimage.2005.09.024","article-title":"Optic nerve diffusion tensor imaging in optic neuritis.","volume":"30","author":"Trip","year":"2006","journal-title":"Neuroimage"},{"key":"R39-3-20210211","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.","volume":"128","author":"Keltner","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R40-3-20210211","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/jnnp.2008.166207","article-title":"Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis.","volume":"80","author":"Green","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R41-3-20210211","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","article-title":"Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.","volume":"73","author":"Ratchford","year":"2009","journal-title":"Neurology"},{"key":"R43-3-20210211","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of lifein multiple sclerosis: correlation with new measures of low and high contrast letter acuity.","volume":"80","author":"Mowry","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R44-3-20210211","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.","volume":"68","author":"Balcer","year":"2007","journal-title":"Neurology"},{"key":"R45-3-20210211","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria.","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"R46-3-20210211","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"R47-3-20210211","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archneurol.2009.107","article-title":"Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability.","volume":"66","author":"Reich","year":"2009","journal-title":"Arch Neurol"},{"key":"R48-3-20210211","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10633-008-9147-4","article-title":"Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship.","volume":"118","author":"Klistorner","year":"2009","journal-title":"Doc Ophthalmol"},{"key":"R49-3-20210211","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"key":"R50-3-20210211","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(95)30839-1","article-title":"What we have learned from the Optic Neuritis Treatment Trial.","volume":"102","author":"Beck","year":"1995","journal-title":"Ophthalmology"},{"key":"R51-3-20210211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10633-007-9072-y","article-title":"Correlation between full-field and multifocal VEPs in optic neuritis.","volume":"116","author":"Klistorner","year":"2008","journal-title":"Doc Ophthalmol"},{"key":"R52-3-20210211","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archneur.63.6.847","article-title":"Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.","volume":"63","author":"Fraser","year":"2006","journal-title":"Arch Neurol"},{"key":"R53-3-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1148\/radiology.206.1.9423652","article-title":"Optic neuritis: MR imaging with combined fat- and water-suppression techniques.","volume":"206","author":"Jackson","year":"1998","journal-title":"Radiology"},{"key":"R54-3-20210211","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002340000450","article-title":"Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence.","volume":"43","author":"Hickman","year":"2001","journal-title":"Neuroradiology"},{"key":"R55-3-20210211","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/brain\/awh284","article-title":"A serial MRI study following optic nerve mean area in acute optic neuritis.","volume":"127","author":"Hickman","year":"2004","journal-title":"Brain"},{"key":"R56-3-20210211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.59.2.250","article-title":"Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves.","volume":"59","author":"Inglese","year":"2002","journal-title":"Arch Neurol"},{"key":"R57-3-20210211","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00415-004-0477-1","article-title":"Visual recovery following acute optic neuritisa clinical, electrophysiological and magnetic resonance imaging study.","volume":"251","author":"Hickman","year":"2004","journal-title":"J Neurol"},{"key":"R58-3-20210211","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.59.5.487","article-title":"Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: correlation with clinical findings and electrophysiology.","volume":"59","author":"Thorpe","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"R59-3-20210211","first-page":"692","article-title":"Serial magnetization transfer imaging in acute optic neuritis.","volume":"127","author":"Hickman","year":"2004","journal-title":"Brain"},{"key":"R60-3-20210211","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/1352458507076952","article-title":"Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis.","volume":"13","author":"Trip","year":"2007","journal-title":"Mult Scler"},{"key":"R61-3-20210211","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.03-1246","article-title":"Demonstration of systematic variation in human intraorbital optic nerve size by quantitative magnetic resonance imaging and histology.","volume":"45","author":"Karim","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R62-3-20210211","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajo.2006.05.042","article-title":"Assessment of axonal degeneration along the human visual pathway using diffusion trace analysis.","volume":"142","author":"Ueki","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R63-3-20210211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.rli.0000195820.98062.c5","article-title":"Fast and quantitative high-resolution magnetic resonance imaging of the optic nerve at 3.0 tesla.","volume":"41","author":"Weigel","year":"2006","journal-title":"Invest Radiol"},{"key":"R64-3-20210211","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hbm.20101","article-title":"Optic radiation changes after optic neuritis detected by tractography-based group mapping.","volume":"25","author":"Ciccarelli","year":"2005","journal-title":"Hum Brain Mapp"},{"key":"R65-3-20210211","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jmri.20178","article-title":"Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis.","volume":"20","author":"Audoin","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"R66-3-20210211","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.20448","article-title":"Adaptive cortical plasticity in higher visual areas after acute optic neuritis.","volume":"57","author":"Toosy","year":"2005","journal-title":"Ann Neurol"},{"key":"R67-3-20210211","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1468-1331.2002.00399.x","article-title":"Functional MRI of the visual cortex and visual testing in patients with previous optic neuritis.","volume":"9","author":"Langkilde","year":"2002","journal-title":"Eur J Neurol"},{"key":"R68-3-20210211","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp.68.4.441","article-title":"Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study.","volume":"68","author":"Werring","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R69-3-20210211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hbm.20863","article-title":"Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.","volume":"31","author":"Jenkins","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"R70-3-20210211","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.neuroimage.2008.05.031","article-title":"Cortical neuroplasticity in patients recovering from acute optic neuritis.","volume":"42","author":"Korsholm","year":"2008","journal-title":"Neuroimage"},{"key":"R71-3-20210211","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.","volume":"329","author":"Beck","year":"1993","journal-title":"N Engl J Med"},{"key":"R74-3-20210211","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.10148","article-title":"Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses.","volume":"51","author":"Beck","year":"2002","journal-title":"Ann Neurol"},{"key":"R75-3-20210211","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/S0149-2918(03)80339-9","article-title":"The effects of intramuscular interferon beta-1a in patients at high risk for development of multiple sclerosis: a post hoc analysis of data from CHAMPS.","volume":"25","author":"OConnor","year":"2003","journal-title":"Clin Ther"},{"key":"R76-3-20210211","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"R77-3-20210211","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and Mc Donald MS in patients with clinically isolated syndromes.","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"R79-3-20210211","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.","volume":"66","author":"Masjuan","year":"2006","journal-title":"Neurology"},{"key":"R80-3-20210211","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/NRL.0b013e31823d7acd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:45Z","timestamp":1786047885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-201201000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31823d7acd","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}